RESMED INC (RMD) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 1073 transactions totaling $293.2M, demonstrating a bearish sentiment with -$293.2M in net insider flow. The most recent transaction on Feb 9, 2026 involved a transaction of 4,991 shares valued at $0.
No significant insider buying has been recorded for RMD in the recent period.
No significant insider selling has been recorded for RMD in the recent period.
Based on recent SEC filings, insider sentiment for RMD is bearish with an Insider Alignment Score of 0/100 and a net flow of -$293.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at RESMED INC (RMD) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading RMD stock, having executed 1073 transactions in the past 90 days. The most active insider is Michael J. Farrell (Executive), who has made 182 transactions totaling $226.6M.
Get notified when executives and directors at RMD file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | J. Farrell Michael | Executive | Option Exercise | 4,991 | $N/A | $0 | |
| Feb 9, 2026 | J. Farrell Michael | Executive | Sale | 4,991 | $273.78 | $1.4M | Large |
| Feb 9, 2026 | J. Farrell Michael | Executive | Option Exercise | 4,991 | $146.34 | $730.4K | Large |
| Jan 7, 2026 | C. Farrell Peter | Executive | Sale | 2,000 | $248.83 | $497.7K | |
| Jan 7, 2026 | J. Farrell Michael | Executive | Option Exercise | 4,991 | $N/A | $0 | |
| Jan 7, 2026 | J. Farrell Michael | Executive | Sale | 4,991 | $248.46 | $1.2M | Large |
| Jan 7, 2026 | J. Farrell Michael | Executive | Option Exercise | 4,991 | $146.34 | $730.4K | Large |
| Dec 8, 2025 | J. Farrell Michael | Executive | Sale | 4,991 | $251.41 | $1.3M | Large |
| Dec 8, 2025 | J. Farrell Michael | Executive | Option Exercise | 4,991 | $146.34 | $730.4K | Large |
| Dec 3, 2025 | C. Farrell Peter | Executive | Sale | 2,000 | $251.47 | $502.9K | Large |
| Dec 1, 2025 | Sandercock Brett | Executive | Sale | 1,000 | $244.16 | $244.2K | |
| Dec 1, 2025 | J. Rider Michael | Executive | Sale | 50 | $244.16 | $12.2K | |
| Nov 25, 2025 | Jan De Witte | Executive | Sale | 2,055 | $255.00 | $524.0K | Large |
| Nov 20, 2025 | C. Farrell Peter | Executive | Award | 536 | $N/A | $0 | |
| Nov 20, 2025 | Jan De Witte | Executive | Award | 1,073 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 437 | $293.2M | 41.0% |
Award(A) | 218 | $198.7M | 27.8% |
Payment(F) | 179 | $145.2M | 20.3% |
Exercise(M) | 202 | $70.7M | 9.9% |
Gift(G) | 37 | $6.8M | 1.0% |
Insider selling pressure at RESMED INC has increased, with 26 insiders executing 1073 transactions across all time. Total sales of $293.2M significantly outpace purchases of $0, resulting in a net outflow of $293.2M. This selling activity appears largely discretionary, which may warrant closer attention from investors.